Two of The American Journal of Managed Care®'s top 5 most-read news stories were themselves top-5 roundups of hot topics in healthcare this year. The list was rounded out by cardiovascular, diabetes, and cancer news.
Two of The American Journal of Managed Care'® (AJMC®)’s top 5 most-read news stories were themselves top-5 roundups of hot topics in healthcare. The list was rounded out by cardiovascular, diabetes, and cancer news.
And 2 of the 5 stories were related to health technology, with one providing a general look at wearables and another about the Freestyle Libre continuous glucose monitoring (CGM) system for patients with diabetes.
5. 5 Vulnerable Populations in Healthcare
For vulnerable populations, health and healthcare issues may be exacerbated by social factors; as a result, they experience worse access to care and increased morbidity and mortality compared with the general population. While a number of vulnerable populations exist, these 5 groups experience greater healthcare disparities: those who are chronically ill and disabled; low-income and/or homeless individuals; certain geographical communities; the LGBTQ+ population; and the very young and very old.
4. 5-Year Survival Rates for Patients With Cancer Worldwide
Using a global surveillance program that documents cancer survival trends, researchers determined the 5-year survival rates of patients diagnosed with 18 types of cancer worldwide. CONCORD-3 includes the records of 37.5 million patients diagnosed with cancer from 2000 to 2014, 322 population-based cancer registries in 71 countries and territories, and data on patients’ vital status at least 5 years following diagnosis.
3. ODYSSEY Outcomes Results for Sanofi’s Praluent to Lead Off ACC Meeting
A preview of the 2018 American College of Cardiology meeting, with a focus on the cardiovascular outcomes results for the PCSK9 inhibitor alirocumab (Praluent) from the ODYSSEY Outcomes trial, was the third most-read story of the year. ODYSSEY sought to determine whether Sanofi-Regeneron’s alirocumab (Praluent) had a superior cardiovascular benefit to Amgen’s evolocumab (Repatha).
2. 5 Things About Wearable Technology in Healthcare
The second most-read story of this year was a look at 5 things to know about wearable technology and healthcare. From consumer gadgets to medical devices that are FDA approved, wearables have implications for cardiology, diabetes, medical adherence, clinical trials, and more.
1. Abbott's Freestyle Libre CGM Gains Medicare Coverage
2018 kicked off with Abbott winning Medicare coverage for its Freestyle Libre CGM system, which requires no regular finger sticks. To receive coverage for therapeutic CGM, a Medicare beneficiary must have type 1 diabetes or be receiving intensive insulin therapy for type 2 diabetes; those eligible must document that their condition requires frequent insulin dosing adjustments, based on checking blood glucose levels at least 4 times a day. Interestingly, Medicare’s 2017 first ruling in favor of CGMs (albeit without allowing the use of smartphones) was the number 1 AJMC® story that year, as well.
Research Points to Potential MCIDs in Diabetes Distress Scale–17
November 29th 2023Researchers identified a value of at least 0.25 to be a minimal clinically important difference (MCID) in diabetes distress, and MCID values of 0.38 and 0.39 for emotional and interpersonal distress subscales and physician and regimen distress subscales, respectively.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More